Bromodomain‑containing protein 7 sensitizes breast cancer cells to paclitaxel by activating Bcl2‑antagonist/killer protein.
Ma J, Niu W, Wang X, Zhou Y, Wang H, Liu F, Liu Y, Guo J, Xiong W, Zeng Z, Fan S, Li X, Nie X, Li G, Gui R, Luo Y, Zhou M.
Ma J, et al.
Oncol Rep. 2019 Mar;41(3):1487-1496. doi: 10.3892/or.2018.6951. Epub 2018 Dec 21.
Oncol Rep. 2019.
PMID: 30592293
Free PMC article.